We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
MOUNJARO (Eli Lilly Australia Pty Ltd)
Product name
MOUNJARO
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
160 (255 working days)
Active ingredients
tirzepatide
Registration type
EOI
Indication
MOUNJARO is now also indicated for the treatment of moderate to severe obstructive sleep apnoea in adults with obesity.